|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
However, few S-100 positive lipoblasts suggested the origin of the tumor.
|
31796335 |
2020 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Shave biopsy and immunohistochemical studies revealed that the tumor was composed of malignant melanoma (MM) (highlighted by S100 and MART-1) intermixed with squamous cell carcinoma (SCC) (highlighted by cytokeratin and p63), and a diagnosis of combined MM-SCC was rendered.
|
31361351 |
2020 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The tumor expressed S100 and was negative for CD31, CD34, desmin, and smooth muscle actin.The expression of p16 was preserved.
|
30421509 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
On IHC, the tumor cells were focally positive for S-100 protein and α-smooth muscle actin; nuclear β-catenin expression was also seen.
|
30592181 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
S100 expression in the periphery of the tumour was typical in 88.2% and 0% for benign and malignant tumors, respectively (p<0.001).
|
30570883 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In cancer, S100 protein expression has been associated with tumor growth, progression, and response to treatment.
|
30710303 |
2019 |
|
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Greater tumor thickness was observed in 25 lesions (69.4%) with S-100, 20 lesions (55.5%) with Melan-A and 17 (47.2%) lesions in HMB-45 rather than H&E staining.
|
30875030 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
NEF is a tumor suppressing long non-coding (lnc)RNA in hepatocellular carcinoma.
|
31258706 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Baseline tumor markers (LDH, S100B), baseline CT imaging biomarkers (tumor burden, Choi density) and CT texture parameters (Entropy, Kurtosis, Skewness, uniformity, MPP, UPP) of the largest target lesion were extracted.
|
31704599 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
S100B serum levels reflect tumor load, correlate with response to treatment, might identify patients who are at increased risk of disease relapse, may predict prognosis independent to LDH, and could be used as early biomarkers of tumor recurrence.
|
29135116 |
2019 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We found that expression of NEF in cervical tissues (tumor tissues for CSCC patients) and serum was significantly down-regulated in HPV-negative CSCC patients than in healthy controls and HPV positive patients, but no significant differences were found between healthy controls and HPV positive patients.
|
30910843 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemically, the tumor was positive for pancytokeratin (AE1/AE3), S-100 protein and CD56, while it was negative for glial fibrillary acid protein, thyroid transcription factor-1, epithelial membrane antigen, other cytokeratins and pituitary hormones.
|
31373070 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The tumour exhibits diffuse positivity for S-100 protein (D) and negativity for GFAP (E).
|
31197414 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Malignant areas of tumor or at the transitional interface showed more intense S100 staining (3/5; 60%).All cases were negative for CEA.
|
30588645 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The S100 calcium-binding protein family are inflammatory molecules that contribute to the development of a pro-inflammatory tumor microenvironment.
|
29345293 |
2018 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Although the tumor location is unusual (but head and neck seated), most of the other clinical, morphologic, immunophenotypic (focal combined expression of S100 protein, SMA, desmin, and myogenin) and oncogenic data suggest that this biphenotypic "oropharyngeal" sarcoma is closely related to the biphenotypic SNS spectrum.
|
29266774 |
2018 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
All tumors showed co-expression of S100 and CD34, ranging from focal to diffuse.SOX10 was negative in all cases.
|
30276917 |
2018 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The immunophenotype of these neoplasms is likewise variable; most cases express glial fibrillary acid protein and S100 protein, with inconsistent reports of keratin and myoid marker expression.
|
29912715 |
2018 |
|
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Serum level of NEF was higher in esophageal squamous-cell carcinoma patients than in healthy controls, and was significantly correlated with tumor size and tumor distant tumor metastasis.
|
30402846 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
S100 proteins take participation in the lung neoplasia through playing intracellular and/or extracellular functions, therefore getting involved in a variety of biological processes such as differentiation, proliferation, and migration.
|
29146477 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Physaliferous cell architecture was shown in the regenerated tumors, which stained positive for Brachyury, cytokeratin, and S100 protein.The tumors showed bone invasion.
|
30248342 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In vivo, however, Dul (30 mg/kg/14 days) inhibited S100B production, altered the polarization and trafficking of tumor-associated myeloid-derived cells, and inhibited the growth of intracranial GL261 gliomas.
|
30076898 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunohistochemical localization of both tyrosine hydroxylase (TH) and S-100 protein in snake aortic rings and brains, as well as in human tissue (paraganglioma tumour) were carried out.
|
30199552 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
ELISAs were performed to analyse the serum levels of hypoxia- and tumour adhesion-related biomarkers (vascular endothelial growth factor (VEGF), interleukin (IL)-8, intracellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM)-1) and markers of tumour aggressiveness (S100 calcium-binding protein B (S100B) and melanoma inhibitory activity (MIA)).
|
29519923 |
2018 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Some of the cells belonging to the solid, proliferative areas, some of the abluminal cells, that are part of the proliferative ductal units and certain myxoid stellate or plasmocytoid cells contain the S100 protein, which would indicate the existence of some processes of mesenchymal epithelial÷myoepithelial transdifferentiation in the development of this type of salivary tumor.
|
28523310 |
2017 |